These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Slow-binding inhibitors of prolyl oligopeptidase with different functional groups at the P1 site. Venäläinen JI; Juvonen RO; Garcia-Horsman JA; Wallén EA; Christiaans JA; Jarho EM; Gynther J; Männistö PT Biochem J; 2004 Sep; 382(Pt 3):1003-8. PubMed ID: 15217351 [TBL] [Abstract][Full Text] [Related]
10. A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors. Jarho EM; Venäläinen JI; Huuskonen J; Christiaans JA; Garcia-Horsman JA; Forsberg MM; Järvinen T; Gynther J; Männistö PT; Wallén EA J Med Chem; 2004 Nov; 47(23):5605-7. PubMed ID: 15509157 [TBL] [Abstract][Full Text] [Related]
11. Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP). Haffner CD; Diaz CJ; Miller AB; Reid RA; Madauss KP; Hassell A; Hanlon MH; Porter DJ; Becherer JD; Carter LH Bioorg Med Chem Lett; 2008 Aug; 18(15):4360-3. PubMed ID: 18606544 [TBL] [Abstract][Full Text] [Related]
12. Substrate-dependent, non-hyperbolic kinetics of pig brain prolyl oligopeptidase and its tight binding inhibition by JTP-4819. Venäläinen JI; Juvonen RO; Forsberg MM; Garcia-Horsman A; Poso A; Wallen EA; Gynther J; Männistö PT Biochem Pharmacol; 2002 Aug; 64(3):463-71. PubMed ID: 12147298 [TBL] [Abstract][Full Text] [Related]
14. An introduction of a pyridine group into the structure of prolyl oligopeptidase inhibitors. Jarho EM; Venäläinen JI; Juntunen J; Yli-Kokko AL; Vepsäläinen J; Christiaans JA; Forsberg MM; Järvinen T; Männistö PT; Wallén EA Bioorg Med Chem Lett; 2006 Nov; 16(21):5590-3. PubMed ID: 16919454 [TBL] [Abstract][Full Text] [Related]
15. 1-((S)-gamma-substituted prolyl)-(S)-2-cyanopyrrolidine as a novel series of highly potent DPP-IV inhibitors. Sakashita H; Kitajima H; Nakamura M; Akahoshi F; Hayashi Y Bioorg Med Chem Lett; 2005 May; 15(10):2441-5. PubMed ID: 15863294 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors. Rönn R; Gossas T; Sabnis YA; Daoud H; Kerblom E; Danielson UH; Sandström A Bioorg Med Chem; 2007 Jun; 15(12):4057-68. PubMed ID: 17449253 [TBL] [Abstract][Full Text] [Related]
17. The natural product berberine is a human prolyl oligopeptidase inhibitor. Tarrago T; Kichik N; Seguí J; Giralt E ChemMedChem; 2007 Mar; 2(3):354-9. PubMed ID: 17295371 [TBL] [Abstract][Full Text] [Related]
18. Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity. Ryabtsova O; Jansen K; Van Goethem S; Joossens J; Cheng JD; Lambeir AM; De Meester I; Augustyns K; Van der Veken P Bioorg Med Chem Lett; 2012 May; 22(10):3412-7. PubMed ID: 22525314 [TBL] [Abstract][Full Text] [Related]